AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

AZN.UK

10,328

+1.65%↑

GSK

1,398

+2.61%↑

INDV

835

+1.46%↑

Search

Haleon PLC

Închisă

SectorSănătate

403.1 0.6

Rezumat

Modificarea prețului

24h

Curent

Minim

401.5

Maxim

406.4

Indicatori cheie

By Trading Economics

Venit

-254M

231M

Vânzări

-21M

2.8B

P/E

Medie Sector

24.919

56.602

EPS

0.042

Randament dividend

1.66

Marjă de profit

8.373

Angajați

24,561

EBITDA

-317M

399M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+3.75% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.66%

2.45%

Următoarele câștiguri

31 iul. 2025

Următoarea dată ex-dividende

14 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

1.9B

36B

Deschiderea anterioară

402.5

Închiderea anterioară

403.1

Sentimentul știrilor

By Acuity

50%

50%

177 / 382 Clasament în Healthcare

Haleon PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

15 apr. 2025, 09:37 UTC

Achiziții, Fuziuni, Preluări

Haleon Acquires Chinese JV in $264 Million Deal

19 mar. 2025, 07:34 UTC

Achiziții, Fuziuni, Preluări

Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion

18 mar. 2025, 17:26 UTC

Achiziții, Fuziuni, Preluări

Pfizer to Dispose of Remaining Shareholding in Haleon

30 apr. 2025, 08:33 UTC

Market Talk
Câștiguri

Haleon's Vitamins & Supplements Business Weakness in Focus Among Results -- Market Talk

30 apr. 2025, 06:09 UTC

Câștiguri

Haleon Expects Macroeconomic Environment to Remain Challenging, Uncertain

30 apr. 2025, 06:09 UTC

Câștiguri

Haleon Continues to Deliver Against Capital Allocation Priorities

30 apr. 2025, 06:08 UTC

Câștiguri

Analysts Saw Haleon 1Q Organic Revenue Growth at 5.1%

30 apr. 2025, 06:03 UTC

Câștiguri

Haleon Sees 2025 Adjusted Operating Profit Growth Ahead of Revenue Growth

30 apr. 2025, 06:03 UTC

Câștiguri

Haleon Sees 2025 Organic Revenue Growth of 4%-6%

30 apr. 2025, 06:03 UTC

Câștiguri

Haleon Backs 2025 View

30 apr. 2025, 06:03 UTC

Câștiguri

Haleon 1Q Rev GBP2.85B

30 apr. 2025, 06:01 UTC

Câștiguri

Haleon 1Q Organic Revenue Growth up 3.5%

29 apr. 2025, 19:47 UTC

Câștiguri

Pfizer Shares Rise on CEO's Optimism on Threatened Drug Tariffs -- Barrons.com

15 apr. 2025, 09:03 UTC

Achiziții, Fuziuni, Preluări

Haleon: Deal Expected to Close Within Next Three Mos

15 apr. 2025, 09:03 UTC

Achiziții, Fuziuni, Preluări

Haleon Has Bought Last 12% Interest for GBP200M

15 apr. 2025, 09:02 UTC

Achiziții, Fuziuni, Preluări

Haleon Bought 33% interest in December 2024

15 apr. 2025, 09:02 UTC

Achiziții, Fuziuni, Preluări

Haleon Buys 33% Interest in Tianjin TSKF Pharmaceutical from Tianjin Pharmaceutical Da Ren Tang

15 apr. 2025, 09:01 UTC

Achiziții, Fuziuni, Preluări

Haleon Buys 33% Interest in Tianjin TSKF Pharmaceutical

18 mar. 2025, 16:58 UTC

Achiziții, Fuziuni, Preluări

Haleon Intends to Cancel Purchased Ordinary Shares

18 mar. 2025, 16:57 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Off-Market Transaction Will Close at Same Time as or Following Settlement of Offering

18 mar. 2025, 16:56 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Off-Market Purchase Worth Approx GBP170M in Ordinary Shares

18 mar. 2025, 16:56 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Haleon Agreed to Carry out Off-Market Purchase From Pfizer

18 mar. 2025, 16:52 UTC

Achiziții, Fuziuni, Preluări

Haleon Takes Note of Announcement

18 mar. 2025, 16:50 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Haleon Won't Receive Any Net Proceeds From Offering

18 mar. 2025, 16:50 UTC

Achiziții, Fuziuni, Preluări

Citigroup: This Is Subject to Customary Closing Conditions

18 mar. 2025, 16:50 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Pfizer Will Receive All of Net Proceeds From Offering

18 mar. 2025, 16:49 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Bookbuilding Period May Close at Any Time on Short Notice

18 mar. 2025, 16:49 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Bookbuilding Period Will Commence Immediately

18 mar. 2025, 16:49 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Price Per Sale Share to Be Determined Through Accelerated Bookbuilding Process

18 mar. 2025, 16:48 UTC

Achiziții, Fuziuni, Preluări

Citigroup: Pfizer Intends to Sell Ordinary Shares to Institutional Investors

Comparație

Modificare preț

Haleon PLC Așteptări

Obiectiv de preț

By TipRanks

3.75% sus

Prognoză pe 12 luni

Medie 416.67 GBX  3.75%

Maxim 475 GBX

Minim 315 GBX

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHaleon PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

12 ratings

7

Cumpărare

4

Păstrare

1

Vânzare

Sentiment

By Acuity

177 / 382 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.